Kenneth I. Kaitin

Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: A regulatory perspective

Olav M. Bakke, Michael Manocchia, Francisco J. de Abajo et al. · Clinical Pharmacology & Therapeutics · 1995 · 209 citations

Assessing the Impact of Protocol Design Changes on Clinical Trial Performance

Kenneth Getz, Julia Wenger, R. Campo et al. · American Journal of Therapeutics · 2008 · 142 citations

Muscarinic Cholinergic Receptors and the Canine Model of Narcolepsy

Thomas S. Kilduff, S. Scott Bowersox, Kenneth I. Kaitin et al. · SLEEP · 1986 · 117 citations · Full text

Preoptic area unit activity during sleep and wakefulness in the cat

Kenneth I. Kaitin · Experimental Neurology · 1984 · 97 citations

Sleep Disorders, Sleep, Neurophysiology +5

Measuring the Incidence, Causes, and Repercussions of Protocol Amendments

Kenneth Getz, Rachael B. Zuckerman, Anne B. Cropp et al. · Drug Information Journal · 2011 · 73 citations

Public Policy, Engineering, Information Security +8